A global player and market leader in sustainable and safe Medical Aesthetics products with a strong culture built on innovation and patients first.

Our view:

  • Tulisma has leading market positions in an attractive and expanding industry segment with healthy growth and continuous growth potentials. Operational performance is strong and outstanding, underpinned by our centralized organization management and decentralized sales and service management
  • During the recent years Tulisma have expanded it territories of market cover to Asia and South America with a strong return on investments and simultaneously one of the markets highest patient satisfaction rate
  • Tulisma create value and hope, trough continuous investments we offer the market safe and efficient, price friendly products which are best-in-class and simultaneously create job opportunities worldwide. The key values is to contribute to people and society by simply being the best
Company facts:
Registered Office
Gothenburg, Sweden
Business Area
Medical Aesthetics
Medical Devices
Share of total assets (%)
100
Ownership capital/votes (%)
100/100
Investment Year
2018
Serving On The Board
Raziyeh Tajari (Chair)
logo2-removebg-preview
A global R&D company with focus on licensing out manufacturing of market leading Pharma & Life science innovations for safe and efficient treatments.

Our view:

  • Göta Pharma & Life is a global Pharma & Life company focused on delivering safe and efficient innovations to worlds all corners. The organization works in all segments based on the current Research and Development demands for present and future. The company has a leading position in licensing out Pharma & Life production technologies globally and are daily growing both in product portfolio and market shares.
  • Göta Pharma & Life has been profiting ever since start and that is a key reason why the organization can continue to be a leading R&D company. Recently Göta Pharma & Life secured an investment from the holding company to secure 10 years of R&D in the field of Anti Diabetics, securing operative work to flow without hindrance and a major research in the field in able to help in treatments of millions of patients worldwide.
  • Our key products currently contains of: Amlodipine/Valsartan, Escitalopram and OTC’s.
  • Current main markets of Göta Pharma & Life contains Asia and Africa, with current benchmarking to continue the growth to South America within 5 years time.
  • Göta Pharma & Life create value and hope, trough continuous investments we offer the market safe and efficient, price friendly products which are best-in-class and simultaneously create job opportunities worldwide. The key values is to contribute to people and society by simply being the best.
Company facts:
Registered Office
Gothenburg, Sweden
Business Area
Pharmaceutical & Life
R&D and production licensing
Share of total assets (%)
100
Ownership capital/votes (%)
100/100
Investment Year
2021
Serving On The Board
Ali Karimi Damavandi (Chair)
logo1-removebg-preview
A global distribution company with sophisticated network of distributors globally for products mainly in the fields of health, pharma & life and commodity trading. Distributing mainly products under the holding but also giving opportunities to non-competing companies to establish global market.

Our view:

  • Nimbright Distribution is well positioned as an international supplier of products in the mentioned three fields. With strong brands, strong organizations, strong financial capability and sophisticated network Nimbright Distribution built up a reputation of being the go-to company to expand internationally.
  • Nimbright Distribution has achieved a strong organic growth, both in sales and profit, for manufacturers all over the world. The ambition is to continue the journey, sustainable and strong, trough specialized management methods and continuously benchmarking towards the industry.
  • Trough recruiting the most talented people, Nimbright Distribution offer a wide range of services, from product development to regulatory and compliance assistance. The manufacturers who trust in Nimbright Distribution gets the whole package to have a sustainable growth.
  • Nimbright Distribution create value and hope, trough continuous investments we offer the market safe and efficient, price friendly products which are best-in-class and simultaneously create job opportunities worldwide. The key values is to contribute to people and society by simply being the best.
Company facts:
Registered Office
Gothenburg, Sweden
Business Area
Distribution of Health
Pharma & Life Commodities
Share of total assets (%)
100
Ownership capital/votes (%)
100/100
Investment Year
2021
Serving On The Board
Ali Karimi Damavandi (Chair)